The American Journal of Psychiatry

最終更新日:2016年10月19日

Topics

2016.01.29

American Journal of Psychiatryで2015年に最も読まれた記事“Most Viewed Articles Top 30”を公開しました。

2014.09.25

American Psychiatric Publishing:プラットフォーム変更のお知らせ

The American Journal of Psychiatry は世界で最も広く読まれている精神医学雑誌です。精神医学のあらゆる側面の最新情報を必要とする精神科医をはじめ、他のメンタルヘルスの専門家にとっても必要不可欠な雑誌です。

 

再認定準備に役立つレビュー・オーバービューや、診断・治療・神経科学・患者人口に関する最新の研究情報を掲載しています。 メンタルヘルスの診断と治療に関連する全範囲をカバーし、革新的研究を臨床に取り入れるための論説を提供します。

出版機関

American Psychiatric Association Publishing (APAP)は、精神医学、メンタルヘルス、行動科学に関する書籍、ジャーナルその他メディアの世界的トップ出版社です。精神科医師、メンタルヘルスの専門家、精神科医の研修医、医学生、そして一般の方々に信頼できる最新の情報を提供しています。

基本情報

Editor-In-Chief:Robert Freedman

Impact Factor: 13.505 (2015)

ISSN (print journal): 0002-953X

ISSN (online): 1535-7228

発行頻度:年12回

巻号(2016年):vol.173

雑誌URL:http://ajp.psychiatryonline.org

 

individual_sub.png

主なカバートピック

障害:薬物乱用、小児精神病理学、気分障害、人格障害

治療方法: 精神薬理学、心理療法、電気けいれん療法

神経科学: 脳イメージング、遺伝学、分子生物学

患者集団: 女性、高齢者、小児など

 

American Journal of Psychiatry: Most Viewed Article Top30 in 2015

 

The American Journal of Psychiatryで2015年1月1日~2015年12月31日の間によく閲覧された記事を30位まで紹介いたします。本ランキングは、出版社より作成の協力を得て弊社独自に発表しております。

論文タイトルをクリックするとAJPの論文ページにジャンプします。

 

Rank Article Title Issue Page
1 Treatment-Resistant Bipolar Depression: A Randomized Controlled Trial of Electroconvulsive Therapy Versus Algorithm-Based Pharmacological Treatment Vol. 172, No. 1, January 2015 41
2 Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study Vol. 172, No. 1, January 2015 52
3 The STRIDE Weight Loss and Lifestyle Intervention for Individuals Taking Antipsychotic Medications: A Randomized Trial Vol. 172, No. 1, January 2015 71
4 Issues for DSM-V: Internet Addiction Vol. 165, No. 3, March 2008 306
5 The Illness of Vincent van Gogh Vol. 159, No. 4, April 2002 519
6 Use of Electroconvulsive Therapy in Bipolar Depression Vol. 172, No. 1, January 2015 3
7

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

Vol. 164, No. 6, June 2007 942
8 Hypercalcemia and “Primary” Hyperparathyroidism During Lithium Therapy Vol. 172, No. 1, January 2015 12
9 Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia Vol. 172, No. 1, January 2015 17
10 Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial Vol. 164, No. 5, May 2007 778
11 A New Intellectual Framework for Psychiatry Vol. 155, No. 4, April 1998 457
12 Impact of Early Intervention on Psychopathology, Crime, and Well-Being at Age 25 Vol. 172, No. 1, January 2015 59
13 A Randomized Trial of Collaborative Depression Care in Obstetrics and Gynecology Clinics: Socioeconomic Disadvantage and Treatment Response Vol. 172, No. 1, January 2015 32
14 Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial Vol. 170, No. 10, October 2013 1134
15 Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments Vol. 170, No. 3, March 2013 275
16 An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline Vol. 171, No. 12, December 2014 1278
17 Pigeon Cave: A Legendary Place of Suicide in Lebanon Vol. 172, No. 1, January 2015 16
18 Disruptive Mood Dysregulation Disorder: A New Diagnostic Approach to Chronic Irritability in Youth Vol. 171, No. 9, September 2014 918
19 Uncovering the Hidden Risk Architecture of the Schizophrenias: Confirmation in Three Independent Genome-Wide Association Studies Vol. 172, No. 2, February 2015 139
20 Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia Vol. 160, No. 1, January 2003 13
21 Insurance, Stigma, and Women’s Mental Health Vol. 172, No. 1, January 2015 1
22 Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects Vol. 171, No. 10, October 2014 1045
23 Pharmacologic Treatments for Borderline Personality Disorder Vol. 171, No. 11, November 2014 1139
24 Comparison of Low and Moderate Dosages of Extended-Release Quetiapine in Borderline Personality Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial Vol. 171, No. 11, November 2014 1174
25 Can Behavioral Health Organizations Change Health Behaviors? The STRIDE Study and Lifestyle Interventions for Obesity in Serious Mental Illness Vol. 172, No. 1, January 2015 9
26 Identification and Replication of a Combined Epigenetic and Genetic Biomarker Predicting Suicide and Suicidal Behaviors Vol. 171, No. 12, December 2014 1287
27

Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorder Questionnaire

Vol. 157, No. 11, November 2000 1873
28 Gray Matter Volume Abnormalities in ADHD: Voxel-Based Meta-Analysis Exploring the Effects of Age and Stimulant Medication Vol. 168, No. 11, November 2011 1154
29 The Risk of Switch to Mania in Patients With Bipolar Disorder During Treatment With an Antidepressant Alone and in Combination With a Mood Stabilizer Vol. 171, No. 10, October 2014 1067
30 The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication Vol. 163, No. 4, April 2006 716

 

購読体系

【個人の場合】 Print + Online (ID / Password 認証)

【法人の場合】Print + Online Online Only (IP Address認証 or ID / Password 認証)

投稿規定

http://ajp.psychiatryonline.org/ajp_ifora

 

※The American Journal of Psychiatryの投稿規程は文献管理・論文作成支援ソフト『EndNote』にサポートされています。

 

mov-btn.gif

カタログ

カタログはこちら PDF

関連商品

                               お問い合わせ/Inquiry